However, its clinical indications were extended, in 2003, to other conditions such as cryopyrin-associated periodic syndrome (CAPS), a group of rare inherited autoinflammatory diseases generally caused by autosomal-dominant mutations in the NLRP3 gene [102]. This evidence concerns the gene NLRP3 and cryopyrin-associated periodic syndrome.